Has Ethel Elad received payments from drug or device companies?

Yes. Drug and device makers reported $3,230 in general payments to Ethel Elad across 145 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ethel Elad did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ethel Elad come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ethel Elad

Psychiatric/Mental Health · Lanham, MDNPI 1033815790

Payments from drug & device makers

$3,230in general payments, 2019–2025

Across 145 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$488
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$457
Lundbeck LLC$422
AbbVie$341
Axsome Therapeutics, Inc.$312
E.r. Squibb & Sons, L.L.C.$220
plus $991 from 13 others

What the payments were for

Food & beverage$3,218100%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	20	$488
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	17	$457
Lundbeck LLC	26	$422
AbbVie	21	$341
Axsome Therapeutics, Inc.	8	$312
E.r. Squibb & Sons, L.L.C.	6	$220
Alkermes, Inc.	9	$192
Neurocrine Biosciences, Inc.	7	$146
Otsuka America Pharmaceutical, Inc.	6	$146
Takeda Pharmaceuticals U.S.A., Inc.	4	$99
Corium, LLC	5	$91
Tris Pharma Inc	4	$76
Ironshore Pharmaceuticals Inc.	3	$69
Teva Pharmaceuticals USA, Inc.	3	$55
Johnson & Johnson	2	$36
Vanda Pharmaceuticals Inc.	1	$26
Bausch Health US, LLC	1	$18
Neos Therapeutics, LP	1	$18
Idorsia Pharmaceuticals US Inc	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,230 in reported general payments places this provider in the 90th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	11	$1,524
Divalproex Sodium	28	$328
Hydroxyzine Hcl	27	$295
Trazodone Hcl	19	$115
Clonazepam	22	$88
Venlafaxine Hcl ErVenlafaxine Hcl	11	$87
Lamotrigine	16	$41
Lorazepam	13	$39

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lanham

Hara OyedejiOwings Mills$780K
Ilya RozenbergGlen Burnie$572K
Michelle WilliamsColumbia$158K
Kristin ClemensGaithersburg$36K
Antonio HeroldHavre de Grace$23K
Paul KlaverweidenFruitland$17K
Margaret WebbAberdeen$16K
Susan KrausTowson$16K
Anyinke AtabongRockville$15K
Zenatsehay GebretsadikColumbia$15K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →